Advisory: Alert from FN Media Group wrongly tagged to multiple companies withdrawn
17/06/2024 14:56
An alert on FN Media Group's Acute Myeloid Leukemia market
report was inadvertently tagged to Acutinium Pharmaceuticals
ATNM.A , Bio Path Holdings BPTH.O , Bristol-Myers Squibb
BMY.N , Sellas Life Sciences Group SLS.O and Longeveron
LGVN.O and has been withdrawn.
There will be no substitute.
STORY_NUMBER: urn:newsml:reuters.com:*:nTUA1KRCHP
STORY_DATE: 17/06/2024
STORY_TIME:[01:45:02 PM GMT]
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities